Chinagene Tech’s ZVS101e Receives FDA IND Approval for Bietti’s Crystalline Dystrophy
Beijing – based Chinagene Tech, a specialist in hereditary ophthalmopathy diagnosis and gene therapy, has...
2023
Jiangxi Leads 16-Province VBP Alliance with Winning Bids Announced
The Jiangxi Province Healthcare Security Administration has released a notification regarding the winning bids of...